全文获取类型
收费全文 | 9102篇 |
免费 | 478篇 |
国内免费 | 59篇 |
专业分类
耳鼻咽喉 | 145篇 |
儿科学 | 147篇 |
妇产科学 | 110篇 |
基础医学 | 1144篇 |
口腔科学 | 227篇 |
临床医学 | 470篇 |
内科学 | 2203篇 |
皮肤病学 | 140篇 |
神经病学 | 682篇 |
特种医学 | 286篇 |
外科学 | 1850篇 |
综合类 | 36篇 |
预防医学 | 206篇 |
眼科学 | 242篇 |
药学 | 703篇 |
中国医学 | 36篇 |
肿瘤学 | 1012篇 |
出版年
2023年 | 68篇 |
2022年 | 40篇 |
2021年 | 208篇 |
2020年 | 127篇 |
2019年 | 170篇 |
2018年 | 194篇 |
2017年 | 172篇 |
2016年 | 195篇 |
2015年 | 217篇 |
2014年 | 220篇 |
2013年 | 305篇 |
2012年 | 463篇 |
2011年 | 457篇 |
2010年 | 246篇 |
2009年 | 242篇 |
2008年 | 397篇 |
2007年 | 454篇 |
2006年 | 401篇 |
2005年 | 405篇 |
2004年 | 399篇 |
2003年 | 407篇 |
2002年 | 373篇 |
2001年 | 292篇 |
2000年 | 349篇 |
1999年 | 274篇 |
1998年 | 89篇 |
1997年 | 56篇 |
1996年 | 60篇 |
1995年 | 68篇 |
1994年 | 54篇 |
1993年 | 62篇 |
1992年 | 198篇 |
1991年 | 157篇 |
1990年 | 199篇 |
1989年 | 197篇 |
1988年 | 180篇 |
1987年 | 178篇 |
1986年 | 193篇 |
1985年 | 136篇 |
1984年 | 97篇 |
1983年 | 74篇 |
1981年 | 31篇 |
1980年 | 34篇 |
1979年 | 76篇 |
1978年 | 55篇 |
1977年 | 41篇 |
1975年 | 33篇 |
1974年 | 40篇 |
1973年 | 33篇 |
1972年 | 33篇 |
排序方式: 共有9639条查询结果,搜索用时 15 毫秒
1.
2.
Hideki Kobara Hirohito Mori Noriko Nishiyama Shintaro Fujihara Keiichi Okano Yasuyuki Suzuki Tsutomu Masaki 《Journal of gastroenterology and hepatology》2019,34(1):22-30
Rescue therapy for gastrointestinal (GI) refractory bleeding, perforation, and fistula has traditionally required surgical interventions owing to the limited performance of conventional endoscopic instruments and techniques. An innovative clipping system, the over‐the‐scope clip (OTSC), may play an important role in rescue therapy. This innovative device is proposed as the final option in endoscopic treatment. The device presents several advantages including having a powerful sewing force for closure of GI defects using a simple mechanism and also having an innovative feature, whereby a large defect and fistula can be sealed using accessory forceps. Consequently, it is able to provide outstanding clinical effects for rescue therapy. This review clarifies the current status and limitations of OTSC according to different indications of GI refractory disease, including refractory bleeding, perforation, fistula, and anastomotic dehiscence. An extensive literature search identified studies reported 10 or more cases in which the OTSC system was applied. A total of 1517 cases described in 30 articles between 2010 and 2018 were retrieved. The clinical success rates and complications were calculated overall and for each indication. The average clinical success rate was 78% (n = 1517) overall, 85% for bleeding (n = 559), 85% (n = 351) for perforation, 52% (n = 388) for fistula, 66% (n = 97) for anastomotic dehiscence, and 95% (n = 122) for other conditions, respectively. The overall and severe OTSC‐associated complications were 1.7% (n = 23) and 0.59% (n = 9), respectively. This review concludes that the OTSC system may serve as a safe and productive device for GI refractory diseases, albeit with limited success for fistula. 相似文献
3.
4.
5.
Takehiko Mori Souichi Shiratori Junji Suzumiya Mineo Kurokawa Motohiro Shindo Uchida Naoyuki Takenaka Katsuto Toshihiro Miyamoto Satoshi Morishige Makoto Hirokawa Takahiro Fukuda Yoshiko Atsuta Ritsuro Suzuki 《Hematological oncology》2020,38(3):266-271
Although allogeneic hematopoietic stem cell transplantation (HSCT) has been reported to provide prolonged remission of relapsed/refractory mycosis fungoides (MF) and Sézary syndrome (SS), its role has not been fully evaluated. Here, the outcomes of allogeneic HSCT for patients with MF/SS were retrospectively evaluated by using the registry database of the Japan Society for Hematopoietic Cell Transplantation. Forty-eight patients were evaluable and enrolled in the analysis. Median age was 45.5 years. Eighteen patients (38%) received myeloablative conditioning, and 33 (69%) received HSCT from an alternative donor. Disease status was complete or partial response in 25% of the patients and relapsed or refractory in the others. At the time of analysis, 18 patients were alive, with a median follow-up of 31.0 months (range, 3.8-31.1). Three-year overall survival (OS) and progression-free survival (PFS) were 30% (95%CI, 16-45%) and 19% (95%CI, 9-31%), respectively. Disease progression was not observed later than 17 months after transplantation. Both disease status and performance status at transplant significantly affected OS and PFS. Although our findings suggest that allogeneic HSCT provides long-term PFS in patients with MF/SS, the timing of transplantation should be decided carefully based on the disease status and the patient's condition in order to improve the outcome. 相似文献
6.
7.
8.
High‐definition optical coherence tomography algorithm for the discrimination of actinic keratosis from normal skin and from squamous cell carcinoma 下载免费PDF全文
9.
Yasushi Sawayama Hidehiro Itonaga Takuya Fukushima Nobuaki Nakano Hiroshi Fujiwara Atae Utsunomiya Takahiro Fukuda Toshihiro Miyamoto Tetsuya Eto Kaname Miyashita Hirohisa Nakamae Masao Ogata Atsushi Yamanoha Yasuhiko Miyazaki Junya Kanda Yoshiko Atsuta Koji Kato ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation 《American journal of hematology》2019,94(5):E143-E146
10.
Marie Ohata Susumu Fujiwara Ai Yoshioka Hiroshi Nagai Shintaro Sugita Nozomi Yamano Yusuke Inoue Chikako Nishigori 《Pediatric dermatology》2019,36(6):997-998
Fibroblastic connective tissue nevus (FCTN) is a benign cutaneous mesenchymal lesion characterized by proliferation of CD34‐positive fibroblastic/myofibroblastic spindle‐shaped cells. We report a case of agminated FCTN on the right lower abdomen of a 1‐year‐old boy. 相似文献